News Round-Up
6 May 2025
The Green Blob Won’t Take This Lying Down
6 May 2025
by Ben Pile
With topsy-turvy results for doses 1 and 2 and confidence intervals wide enough to drive a bus through, PHE's latest vaccine study leaves a lot to be desired.
When the infectiousness (secondary attack rate) of the Delta variant over time is plotted against that of other variants it becomes clear that claims it is hyper-transmissible make no sense.
PHE released their latest technical briefing yesterday which claims the Delta variant is 64% more infectious than the Alpha variant. But look closer and this headline finding is not all it seems.
No vaccine passports (they're banned), no tests, no masks, no distancing – 22,000 people packed together for an outdoor live music event in Florida. Is the dithering UK Government paying attention?
Rising infections are blamed on the Indian variant that PHE now claims causes twice as serious illness and talk has turned to continuing with restrictions. We've been here before.
In its third weekly vaccine surveillance report, PHE revises down its estimate of AZ efficacy to a lower bound of 65%. Are Government scientists becoming worried about the fitness of their "workhorse" vaccine?
The coronavirus crisis will be over in the U.K. shortly if the current vaccines work against the Indian variant, one of the country's top scientists said on the Today programme.
On Thursday, PHE releases a study showing the AZ vaccine is 90% effective in the over-65s. On Saturday, they release a study showing just it is 66% effective across all ages. Why is no one asking questions about this?
New data from PHE suggests the vaccines are 90% effective in preventing symptomatic infection in the over 65s. But the study has numerous problems. It also shows the post-vaccine infection spike again.
Cases are down in every region in England and fewer over-80s are catching the virus than ever before, according to PHE. So why are restrictions not being lifted for another seven weeks? What happened to data not dates?
© Skeptics Ltd.